ArticleCancers2023

Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab.

Matthias Jeschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.